Magyar Bancorp: Earnings, NII and loan growth up; CRE concentration and cash shrink pose risks

Quick take - Magyar Bancorp, Inc. (NASDAQ: MGYR)

Magyar Bancorp's latest 10‑Q (period ended June 30, 2025) shows a bank in growth mode: loans and net interest income are up, profitability improved materially year‑over‑year, and capital strengthened. At the same time liquidity shifted from cash into loans, loan portfolio concentration in commercial real estate rose, unrealized securities losses remain, and provisions ticked higher this quarter.

Key facts & figures (as reported)
* Total assets: $987,488 (in thousands) at June 30, 2025 vs $951,918 at Sept. 30, 2024.
* Loans receivable (gross): $845,410 (in thousands); loans receivable, net: $843,991 (in thousands) at June 30, 2025 (up from $780,162).
* Commercial real estate loans: $523,990 (in thousands) - 100% of CRE portfolio; owner‑occupied $228,671 (43.6%), non‑owner occupied $295,319 (56.4%).
* Deposits: $819,962 (in thousands) at June 30, 2025 (up from $796,674). Brokered CDs included $41.3 million.
* Cash and cash equivalents: $7,051 (in thousands) vs $25,596 at Sept. 30, 2024 (sharp decline).
* Investment securities - available‑for‑sale fair value: $21,604 (in thousands); held‑to‑maturity amortized cost: $69,520 (in thousands) (fair value $62,591).
* Unrealized losses on AFS securities: $1,198 (in thousands) (total investment securities unrealized losses shown).
* Net income (quarter): $2,470 (in thousands) for Q3 2025 vs $1,691 for Q3 2024 (+46.1%).
* Net income (nine months): $7,235 (in thousands) vs $5,240 for prior nine months (+38.1%).
* EPS - basic/diluted (quarter): $0.40 vs $0.27; nine months: $1.16 vs $0.82.
* Net interest and dividend income (quarter): $8,178 (in thousands) vs $6,784; net interest margin 3.35% (quarter) vs 3.02% prior.
* Interest income (quarter): $13,988 (in thousands); interest expense (quarter): $5,810 (in thousands).
* Provision for (recovery of) credit losses (quarter): $101 (in thousands) vs a net recovery of $(54) in Q3 2024; YTD provision $172 vs $441 prior year.
* Allowance for credit losses - loans: $8,059 (in thousands) at June 30, 2025 (up from $7,548); ACL ≈ 0.98% of loans (company disclosure).
* Non‑performing loans: $920 (in thousands) at June 30, 2025 vs $232 at Sept. 30, 2024 (ratio to loans 0.11% vs 0.03%).
* Borrowings: $36,054 (in thousands) (up from $28,568).
* Stockholders' equity / book value per share: $116,323 (in thousands); book value per share $18.03; shares outstanding 6,450,948.

What's happening inside the company
* Loan growth is the operational focus - management deployed interest‑earning deposits into loans: loans rose $64.2M (8.2%) since Sept. 30, 2024, driven by commercial real estate (+$62.7M).
* Net interest income and margins improved as yields on loans rose and loan balances increased - NII up materially quarter and YTD, lifting profitability.
* Management used borrowed funds and brokered deposits to fund loan growth (borrowings up ~$7.5M; brokered CDs up ~$11.7M vs Sept. 30, 2024).
* Liquidity mix shifted: cash and interest‑earning deposits fell sharply (cash and equivalents down to $7,051 from $25,596) as funds were deployed into lending and securities purchases.
* Capital and shareholder returns: earnings drove equity up; the company continued buybacks (repurchased 60,410 shares YTD, treasury 646,877 shares) and paid dividends ($0.21 per share YTD).

Positive income‑statement items
* Net income jumped to $2,470 (in thousands) for the quarter (+46% YoY) and $7,235 (in thousands) YTD (+38% YoY).
* Net interest and dividend income increased to $8,178 (in thousands) (quarter), supported by higher loan yields and larger loan balances; net interest margin expanded to 3.35% (quarter).
* Other income improved: $636 (in thousands) for the quarter (up from $409), driven by higher BOLI income, service charges and SBA loan sale gains YTD ($848 for nine months).
* Efficiency toward revenue growth: loan‑driven revenue growth outpaced interest expense increases - interest expense rose modestly relative to interest income.

Negative income‑statement / risk items
* Provision for credit losses moved from a net recovery in Q3 2024 to a $101 (in thousands) net provision this quarter - tied to growth in CRE and other loan segments.
* Non‑performing loans increased to $920 (in thousands) (3.96x increase from Sept. 30, 2024) - still small as a percentage of loans (0.11%) but the trend is upward.
* Non‑interest expense rose (compensation and benefits +7.3% QoQ contribution) - total other expenses $5,239 (in thousands) Q3 vs $5,055 prior.
* Income tax expense increased substantially (effective tax rate 28.9% Q3 2025 vs 22.9% prior), reducing net margin improvement.
* Liquidity and concentration risk: cash and interest‑bearing deposits dropped (cash down to $7,051), CRE concentration is high - CRE $523,990 (in thousands) of loans and non‑owner occupied CRE to capital = elevated (company estimate ~266% of risk‑based capital).
* Unrealized losses in available‑for‑sale securities: unrealized AFS loss $1,198 (in thousands); held‑to‑maturity securities fair value below amortized cost ($62,591 fair vs $69,520 cost AMT).
* Greater reliance on wholesale funding: brokered deposits and FHLB advances increased compared with Sept. 30, 2024.

Bottom line / near‑term watch items
* Earnings momentum is real: NII, NIM and EPS are all up - loan growth is feeding revenue.
* Key risks: rising CRE exposure, shrinking cash buffer, increased borrowings and brokered deposits, and a recent rise in non‑performing loans and provisions. Monitor asset quality metrics, ACL changes, liquidity (quarterly cash and deposit flows), and the CRE portfolio performance.
* Balance sheet strength: capital remains solid (total stockholders' equity $116,323 in thousands; Tier 1 and capital ratios disclosed as healthy), and management continues buybacks and dividends - signaling confidence, but also consuming capital.

If you want, I can convert these points into a short investor memo, a slide deck, or a one‑page risk checklist focused on CRE concentration and liquidity metrics.